Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'C-ERBB-2 ONCOGENE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skirnisdottir, I; Sorbe, B; Seidal, T
      The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    2. Arencibia, JM; Schally, AV; Krupa, M; Bajo, AM; Nagy, A; Szepeshazi, K; Plonowski, A
      Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness

      INTERNATIONAL JOURNAL OF ONCOLOGY
    3. Menard, S; Casalini, P; Campiglio, M; Pupa, S; Agresti, R; Tagliabue, E
      HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer

      ANNALS OF ONCOLOGY
    4. Scholl, S; Beuzeboc, P; Pouillart, P
      Targeting HER2 in other tumor types

      ANNALS OF ONCOLOGY
    5. Koeppen, HKW; Wright, BD; Burt, AD; Quirke, P; McNicol, AM; Dybdal, NO; Sliwkowski, MX; Hillan, KJ
      Overexpression of HER2/neu in solid tumours: an immunohistochemical survey

      HISTOPATHOLOGY
    6. Yaziji, H; Gown, AM
      Immunohistochemical analysis of gynecologic tumors

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    7. Stark, A; Hulka, BS; Joens, S; Novotny, D; Thor, AD; Wold, LE; Schell, MJ; Melton, LJ; Liu, ET; Conway, K
      HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    8. Lippert, TH; Seeger, H; Mueck, AO
      The impact of endogenous estradiol metabolites on carcinogenesis

      STEROIDS
    9. Feig, SA
      Ductal carcinoma in situ - Implications for screening mammography

      RADIOLOGIC CLINICS OF NORTH AMERICA
    10. Ho, GH; Calvano, JE; Bisogna, M; Borgen, PI; Rosen, PP; Tan, LK; Van Zee, KJ
      In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology

      CANCER
    11. Polkowski, W; van Sandick, JW; Offerhaus, GJA; ten Kate, FJW; Mulder, J; Obertop, H; van Lanschot, JJB
      Prognostic value of Lauren classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction

      ANNALS OF SURGICAL ONCOLOGY
    12. Harbeck, N; Ross, JS; Yurdseven, S; Dettmar, P; Polcher, M; Kuhn, W; Ulm, K; Graeff, H; Schmitt, M
      HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    13. Okuyama, N; Hatano, Y; Park, Y; Shimatani, S; Sasamoto, S; Katou, N; Takagi, K; Yamazaki, S; Inoue, A; Hemmi, H; Shimatake, H; Yanagida, M; Miura, M
      Quantitation of c-erbB-2 gene amplification in breast cancer tissue by competitive PCR

      TUMOR BIOLOGY
    14. Tantawy, A; Youins, L; Hamza, M
      Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation toinvasion of the cartilagenous framework and prognosis

      EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
    15. Gonzalez-Sancho, JM; Alvarez-Dolado, M; Caelles, C; Munoz, A
      Inhibition of tenascin-C expression in mammary epithelial cells by thyroidhormone

      MOLECULAR CARCINOGENESIS
    16. Esserman, LJ; Lopez, T; Montes, R; Bald, LN; Fendly, BM; Campbell, MJ
      Vaccination with the extracellular domain of p185(neu) prevents mammary tumor development in neu transgenic mice

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    17. Ceccarelli, C; Santini, D; Gamberini, M; Taffurelli, M; Chieco, P; Piana, S; Pileri, S; Marrano, D
      Immunohistochemical expression of internal and external ErbB-2 domains in invasive breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    18. Tarkkanen, M; Elomaa, I; Blomqvist, C; Kivioja, AH; Kellokumpu-Lehtinen, P; Bohling, T; Valle, J; Knuutila, S
      DNA sequence copy number increase at 8q: A potential new prognostic markerin high-grade osteosarcoma

      INTERNATIONAL JOURNAL OF CANCER
    19. Raggi, CC; Bagnoni, ML; Tonini, GP; Maggi, M; Vona, G; Pinzani, P; Mazzocco, K; De Bernardi, B; Pazzagli, M; Orlando, C
      Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system

      CLINICAL CHEMISTRY
    20. Nakajima, M; Sawada, H; Yamada, Y; Watanabe, A; Tatsumi, M; Yamashita, J; Matsuda, M; Sakaguchi, T; Hirao, T; Nakano, H
      The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

      CANCER
    21. ORLANDO C; PINZANI P; PAZZAGLI M
      DEVELOPMENTS IN QUANTITATIVE PCR

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    22. LAWRENCE JA; MERINO MJ; SIMPSON JF; MANROW RE; PAGE DL; STEEG PS
      A HIGH-RISK LESION FOR INVASIVE BREAST-CANCER, DUCTAL CARCINOMA IN-SITU, EXHIBITS FREQUENT OVEREXPRESSION OF RETINOID-X-RECEPTOR

      Cancer epidemiology, biomarkers & prevention
    23. WIECHEN K; ZIMMER C; DIETEL M
      SELECTION OF A HIGH-ACTIVITY C-ERBB-2 RIBOZYME USING A FUSION GENE OFC-ERBB-2 AND THE ENHANCED GREEN FLUORESCENT PROTEIN

      Cancer gene therapy
    24. Papahadjopoulos, D; Kirpotin, DB; Park, JW; Hong, KL; Shao, Y; Shalaby, R; Colbern, G; Benz, CC
      Targeting of drugs to solid tumors using anti-HER2 immunoliposomes

      JOURNAL OF LIPOSOME RESEARCH
    25. Schafer, KA; Kelly, G; Schrader, R; Griffith, WC; Muggenburg, BA; Tierney, LA; Lechner, JE; Janovitz, EB; Hahn, FF
      A canine model of familial mammary gland neoplasia

      VETERINARY PATHOLOGY
    26. Sugg, SL; Ezzat, S; Zheng, L; Rosen, IB; Freeman, JL; Asa, SL
      Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia

      CLINICAL ENDOCRINOLOGY
    27. ORTIZHIDALGO C; DELAVEGA G; AGUIRREGARCIA J
      THE HISTOPATHOLOGY AND BIOLOGIC PROGNOSTIC FACTORS OF BARRETTS-ESOPHAGUS - A REVIEW

      Journal of clinical gastroenterology
    28. Manavi, M; Berger, A; Kucera, E; Schneeweiss, A; Kucera, H; Kubista, E; Czerwenka, K
      Amplification and expression of the c-erbB-2 oncogene in Mullerian-derivedgenital-tract tumors

      GYNECOLOGIC ONCOLOGY
    29. Hata, H; Hamano, M; Watanabe, J; Kuramoto, H
      Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells

      ONCOLOGY
    30. ADAMS GP; SCHIER R; MCCALL AM; CRAWFORD RS; WOLF EJ; WEINER LM; MARKS JD
      PROLONGED IN-VIVO TUMOR RETENTION OF A HUMAN DIABODY TARGETING THE EXTRACELLULAR DOMAIN OF HUMAN HER2 NEU/

      British Journal of Cancer
    31. MOHAMOOD AS; GYLES P; BALAN KV; HOLLIS VW; ECKBERG WR; ASSEFFA A; HAN Z; WYCHE JH; ANDERSON WA
      ESTROGEN-RECEPTOR, GROWTH-FACTOR RECEPTOR AND PROTOONCOGENE PROTEIN ACTIVITIES AND POSSIBLE SIGNAL-TRANSDUCTION CROSSTALK IN ESTROGEN-DEPENDENT AND INDEPENDENT BREAST-CANCER CELL-LINES

      Journal of submicroscopic cytology and pathology
    32. BRIGANTI V; SESTINI R; ORLANDO C; BERNINI G; LACAVA G; TAMBURINI A; RAGGI CC; SERIO M; MAGGI M
      IMAGING OF SOMATOSTATIN RECEPTORS BY INDIUM-111-PENTETREOTIDE CORRELATES WITH QUANTITATIVE-DETERMINATION OF SOMATOSTATIN RECEPTOR-TYPE-2 GENE-EXPRESSION IN NEUROBLASTOMA TUMORS

      Clinical cancer research
    33. CHEN H; YU DH; CHINNADURAI G; KARUNAGARAN D; HUNG MC
      MAPPING OF ADENOVIRUS-5 E1A-DOMAINS RESPONSIBLE FOR SUPPRESSION OF NEU-MEDIATED TRANSFORMATION VIA TRANSCRIPTIONAL REPRESSION OF NEU

      Oncogene
    34. BECKMANN MW; NIEDERACHER D; SCHNURCH HG; GUSTERSON BA; BENDER HG
      MULTISTEP CARCINOGENESIS OF BREAST-CANCER AND TUMOR HETEROGENEITY

      Journal of molecular medicine
    35. COENE ED; SCHELFHOUT V; WINKLER RA; SCHELFHOUT AM; VANROY N; GROOTECLAES M; SPELEMAN F; DEPOTTER CR
      AMPLIFICATION UNITS AND TRANSLOCATION AT CHROMOSOME 17Q AND C-ERBB-2 OVEREXPRESSION IN THE PATHOGENESIS OF BREAST-CANCER

      Virchows Archiv
    36. DUGAN MC; DERGHAM ST; KUCWAY R; SINGH K; BIERNAT L; DU W; VAITKEVICIUS VK; CRISSMAN JD; SARKAR FH
      HER-2 NEU EXPRESSION IN PANCREATIC ADENOCARCINOMA - RELATION TO TUMORDIFFERENTIATION AND SURVIVAL/

      Pancreas
    37. NAKAI T; ISHIMA R; SAKAHARA H; ENDO K; KONISHI J; AKASAKA K
      AN IN-VITRO H-1-MRS MODEL OF ONCOGENE TRANSFECTION - THE SPECTRAL FEATURE OF C-ERBB-2 AND C-HA-RAS TRANSFECTED NIH3T3 FIBROBLAST CELLS

      Acta radiologica
    38. ARAI Y; YOSHIKI T; YOSHIDA O
      C-ERBB-2 ONCOPROTEIN - A POTENTIAL BIOMARKER OF ADVANCED PROSTATE-CANCER

      The Prostate
    39. IBRAHIM SO; VASSTRAND EN; LIAVAAG PG; JOHANNESSEN AC; LILLEHAUG JR
      EXPRESSION OF C-ERBB PROTOONCOGENE FAMILY MEMBERS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Anticancer research
    40. BODEY B; BODEY B; GROGER AM; LUCK JV; SIEGEL SE; TAYLOR CR; KAISER HE
      CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF THE EXPRESSION OF THE C-ERBB-2 AND C-ERBB-3 ONCOPROTEINS IN PRIMARY AND METASTATIC MALIGNANT MELANOMAS AND BREAST CARCINOMAS

      Anticancer research
    41. SELLI C; AMOROSI A; VONA G; SESTINI R; TRAVAGLINI F; BARTOLETTI R; ORLANDO C
      RETROSPECTIVE EVALUATION OF C-ERBB-2 ONCOGENE AMPLIFICATION USING COMPETITIVE PCR IN COLLECTING DUCT CARCINOMA OF THE KIDNEY

      The Journal of urology
    42. KAPITANOVIC S; RADOSEVIC S; KAPITANOVIC M; ANDELINOVIC S; FERENCIC Z; TAVASSOLI M; PRIMORAC D; SONICKI Z; SPAVENTI S; PAVELIC K; SPAVENTI R
      THE EXPRESSION OF P185(HER-2 NEU) CORRELATES WITH THE STAGE OF DISEASE AND SURVIVAL IN COLORECTAL-CANCER/

      Gastroenterology
    43. NOWAK F; JACQUEMINSABLON A; PIERRE J
      EXPRESSION OF THE ACTIVATED P185(ERBB2) TYROSINE KINASE IN HUMAN EPITHELIAL-CELLS LEADS TO MAP KINASE ACTIVATION BUT DOES NOT CONFER ONCOGENICITY

      Experimental cell research
    44. TRONCONE G; PANICO L; VETRANI A; DEDIVITIIS B; ZEPPA P; FULCINITI F; PETTINATO G; PALOMBINI L
      C-ERBB-2 EXPRESSION IN FNAB SMEARS AND MATCHED SURGICAL SPECIMENS OF BREAST-CANCER

      Diagnostic cytopathology
    45. SESTINI R; ORLANDO C; PERI A; TRICARICO C; PAZZAGLI M; SERIO M; PAGANI A; BUSSOLATI G; GRANCHI S; MAGGI M
      QUANTITATION OF SOMATOSTATIN RECEPTOR-TYPE-2 GENE-EXPRESSION IN NEUROBLASTOMA CELL-LINES AND PRIMARY TUMORS USING COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION

      Clinical cancer research
    46. KING CR; FISCHER PH; RANDO RF; PASTAN I
      THE PERFORMANCE OF E23(FV)PES, RECOMBINANT TOXINS TARGETING THE ERBB-2 PROTEIN

      Seminars in cancer biology
    47. TOMMASI S; DITONNO P; SISTO MR; PARADISO A; GENTILE A; RICCO R; SCHITTULLI F; JACOBELLIS U
      HER-2 NEU IN BLADDER-CARCINOMA

      International journal of oncology
    48. INOUE A; HASAN Z; HEMMI H; KANDA N; HAYASHI Y; ISHIZAWA T; TSUCHIDA Y; SHIMATAKE H
      COMPETITIVE POLYMERASE CHAIN-REACTION FOR THE QUANTIFICATION OF N-MYCGENE COPY NUMBER IN NEUROBLASTOMA

      Tumor biology
    49. MILLIS RR; BOBROW LG; BARNES DM
      IMMUNOHISTOCHEMICAL EVALUATION OF BIOLOGICAL MARKERS IN MAMMARY-CARCINOMA IN-SITU - CORRELATION WITH MORPHOLOGICAL FEATURES AND RECENTLY PROPOSED SCHEMES FOR HISTOLOGICAL CLASSIFICATION

      Breast
    50. RODRIGO JP; RAMOS S; LAZO PS; ALVAREZ I; SUAREZ C
      AMPLIFICATION OF ERBB ONCOGENES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK

      European journal of cancer
    51. XING XM; MATIN A; YU DH; XIA WY; SORGI F; HUANG L; HUNG MC
      MUTANT SV40 LARGE T-ANTIGEN AS A THERAPEUTIC AGENT FOR HER-2 NEU-OVEREXPRESSING OVARIAN-CANCER/

      Cancer gene therapy
    52. GU KF; MESMASSON AM; GAUTHIER J; SAAD F
      OVEREXPRESSION OF HER-2 NEU IN HUMAN PROSTATE-CANCER AND BENIGN HYPERPLASIA/

      Cancer letters
    53. YAZICI H; MUSLUMANOGLU M; GUZEY D; YASASEVER V; OZBEK U; DALAY N
      AMPLIFICATION IN TUMORS AND BENIGN TISSUE OF BREAST-CANCER PATIENTS

      Cancer letters
    54. PAULEY RJ; GIMOTTY PA; PAINE TJ; DAWSON PJ; WOLMAN SR
      INT2 AND ERBB2 AMPLIFICATION AND ERBB2 EXPRESSION IN BREAST-TUMORS FROM PATIENTS WITH DIFFERENT OUTCOMES

      Breast cancer research and treatment
    55. CHOZICK BS; BENZIL DL; STOPA EG; PEZZULLO JC; KNUCKEY NW; EPSTEIN MH; FINKELSTEIN SD; FINCH PW
      IMMUNOHISTOCHEMICAL EVALUATION OF ERBB-2 AND P53 PROTEIN EXPRESSION IN BENIGN AND ATYPICAL HUMAN MENINGIOMAS

      Journal of neuro-oncology
    56. HUGHES KS; LEE AK; ROLFS A
      CONTROVERSIES IN THE TREATMENT OF DUCTAL CARCINOMA IN-SITU

      The Surgical clinics of North America
    57. FUJIMOTO J; SHIOTA M; IWAHARA T; SEKI N; SATOH H; MORI S; YAMAMOTO T
      CHARACTERIZATION OF THE TRANSFORMING ACTIVITY OF P80, A HYPERPHOSPHORYLATED PROTEIN IN A KI-1 LYMPHOMA CELL-LINE WITH CHROMOSOMAL TRANSLOCATION T(2-5)

      Proceedings of the National Academy of Sciences of the United Statesof America
    58. THOMAS H; HANBY AM; SMITH RA; HAGGER P; PATEL K; RAIKUNDALIA B; CAMPLEJOHN RS; BALKWILL FR
      AN INBRED COLONY OF ONCOGENE TRANSGENIC MICE - DIVERSITY OF TUMORS AND POTENTIAL AS A THERAPEUTIC MODEL

      British Journal of Cancer
    59. MOLLAND JG; BARRACLOUGH BH; GEBSKI V; MILLIKEN J; BILOUS M
      PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 ONCOGENE IN AXILLARY NODE-NEGATIVE BREAST-CANCER

      Australian and New Zealand journal of surgery
    60. JACQUINET E; BROSENS L; WINKLER R; COIGNOUL F
      GROWTH-FACTOR RECEPTOR CHANGES IN EPITHEL IAL NEOPLASTIC PROCESSES

      Annales de medecine veterinaire
    61. STEEG PS; CLARE SE; LAWRENCE JA; ZHOU Q
      MOLECULAR ANALYSIS OF PREMALIGNANT AND CARCINOMA IN-SITU LESIONS OF THE HUMAN BREAST

      The American journal of pathology
    62. BHAT HK; SPRINGER I; RAJARAMAN S; LIEHR JG
      DIFFERENTIAL EXPRESSION OF NEU MESSENGER-RNA AND PROTEIN IN HAMSTER-KIDNEY AND ESTROGEN-INDUCED KIDNEY TUMORS

      International journal of oncology
    63. ALIMANDI M; ROMANO A; CURIA MC; MURARO R; FEDI P; AARONSON SA; DIFIORE PP; KRAUS MH
      COOPERATIVE SIGNALING OF ERBB3 AND ERBB2 IN NEOPLASTIC TRANSFORMATIONAND HUMAN MAMMARY CARCINOMAS

      Oncogene
    64. VALONE FH; KAUFMAN PA; GUYRE PM; LEWIS LD; MEMOLI V; DEO Y; GRAZIANO R; FISHER JL; MEYER L; MROZEKORLOWSKI M; WARDWELL K; GUYRE V; MORLEY TL; ARVIZU C; FANGER MW
      PHASE IA IB TRIAL OF BISPECIFIC ANTIBODY MDX-210 IN PATIENTS WITH ADVANCED BREAST OR OVARIAN-CANCER THAT OVEREXPRESSES THE PROTOONCOGENE HER-2/NEU/

      Journal of clinical oncology
    65. LOPEZBARAHONA M; FIALKA I; GONZALEZSANCHO JM; ASUNCION M; GONZALEZ M; IGLESIAS T; BERNAL J; BEUG H; MUNOZ A
      THYROID-HORMONE REGULATES STROMELYSIN EXPRESSION, PROTEASE SECRETION AND THE MORPHOGENETIC POTENTIAL OF NORMAL POLARIZED MAMMARY EPITHELIAL-CELLS

      EMBO journal
    66. MILLIKAN R; DRESSLER L; GERADTS J; GRAHAM M
      THE NEED FOR EPIDEMIOLOGIC STUDIES OF IN-SITU CARCINOMA OF THE BREAST

      Breast cancer research and treatment
    67. ADAMS GP; MCCARTNEY JE; WOLF EJ; EISENBERG J; HUSTON JS; BOOKMAN MA; MOLDOFSKY P; STAFFORD WF; HOUSTON LL; WEINER LM
      ENHANCED TUMOR SPECIFICITY OF 741F8-1(SFV')(2), AN ANTI-C-ERBB-2 SINGLE-CHAIN FV DIMER, MEDIATED BY STABLE RADIOIODINE CONJUGATION

      The Journal of nuclear medicine
    68. FELIP E; ENCABO G; VIDAL MT; VERA R; DELCAMPO JM; RUBIO D
      THE C-ERBB PROTEIN IN OVARIAN EPITHELIAL CANCER - THE CORRELATION BETWEEN EXPRESSION IN TUMORAL TISSUE AND SERUM VALUES

      Medicina Clinica
    69. RUBIN JS; QIU L; ETKIND P
      AMPLIFICATION OF THE INT-2 GENE IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Journal of Laryngology and Otology
    70. OHNISHI Y; NAKAMURA H; YOSHIMURA M; TOKUDA Y; IWASAWA M; UEYAMA Y; TAMAOKI N; SHIMAMURA K
      PROLONGED SURVIVAL OF MICE WITH HUMAN GASTRIC-CANCER TREATED WITH AN ANTI-C-ERBB-2 MONOCLONAL-ANTIBODY

      British Journal of Cancer
    71. SCHMITT FC; FIGUEIREDO P; LACERDA M
      EXPRESSION OF C-ERB B-2 PROTEIN AND DNA-PLOIDY IN BREAST CARCINOGENESIS

      Archives of pathology and laboratory medicine
    72. ELHABASHI A; ELMORSI B; FREEMAN SM; ELDIDI M; MARROGI AJ
      TUMOR ONCOGENIC EXPRESSION IN MALIGNANT EFFUSIONS AS A POSSIBLE METHOD TO ENHANCE CYTOLOGIC DIAGNOSTIC SENSITIVITY - AN IMMUNOCYTOCHEMICAL STUDY OF 87 CASES

      American journal of clinical pathology
    73. BREUER B; DEVIVO I; LUO JC; SMITH S; PINCUS MR; TATUM AH; DAUCHER J; MINICK CR; MILLER DG; NOWAK EJ; CODY HS; NIMAN H; CARNEY WP; BRANDTRAUF PW
      ERBB-2 AND MYC ONCOPROTEINS IN SERA AND TUMORS OF BREAST-CANCER PATIENTS

      Cancer epidemiology, biomarkers & prevention
    74. TOMMASI S; RELLA C; GIANNELLA C; QUARANTA M; SCHITTULLI F; PARADISO A; COVIELLO M; DELENA M
      HER-2 NEU AND FIBRINOLYTIC FACTORS IN HUMAN BREAST-CANCER/

      International journal of oncology
    75. SHIOTA M; FUJIMOTO J; SEMBA T; SATOH H; YAMAMOTO T; MORI S
      HYPERPHOSPHORYLATION OF A NOVEL 80 KDA PROTEIN-TYROSINE KINASE SIMILAR TO LTK IN A HUMAN KI-1 LYMPHOMA CELL-LINE, AMS3

      Oncogene
    76. GRUNT TW; HUBER H
      THE FAMILY OF C-ERBB GENES - FROM BASIC RESEARCH TO CLINICAL ONCOLOGY

      Onkologie
    77. KARJA V; SYRJANEN S; KATAJA V; SYRJANEN K
      C-ERBB-2 ONCOGENE EXPRESSION IN SALIVARY-GLAND TUMORS

      ORL
    78. ISHIDA T; TSUJISAKI M; HANZAWA Y; HIRAKAWA T; HINODA Y; IMAI K; YACHI A
      SIGNIFICANCE OF ERBB-2 GENE-PRODUCT AS A TARGET MOLECULE FOR CANCER-THERAPY

      Scandinavian journal of immunology
    79. NAKOPOULOU L; STEFANAKI K; FILAKTOPOULOS D; GIANNOPOULOU I
      C-ERB-B-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN HEPATOCELLULAR-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY

      Histology and histopathology
    80. HYYTINEN E; VISAKORPI T; KALLIONIEMI A; KALLIONIEMI OP; ISOLA JJ
      IMPROVED TECHNIQUE FOR ANALYSIS OF FORMALIN-FIXED, PARAFFIN-EMBEDDED TUMORS BY FLUORESCENCE IN-SITU HYBRIDIZATION

      Cytometry
    81. JENNINGS TS; DOTTINO PR; MANDELL JP; SEGNA RA; KELLIHER K; COHEN CJ
      GROWTH-FACTOR EXPRESSION IN NORMAL PERITONEUM OF PATIENTS WITH GYNECOLOGIC CARCINOMA

      Gynecologic oncology
    82. SCHWECHHEIMER K; LAUFLE RM; SCHMAHL W; KNODLSEDER M; FISCHER H; HOFLER H
      EXPRESSION OF NEU C-ERBB-2 IN HUMAN BRAIN-TUMORS/

      Human pathology
    83. LUCASSEN E; ANDRES AC; REICHMANN E; ENTWISTLE A; NOBLE M
      THE EFFECTS OF THE NEUN AND NEUT GENES ON DIFFERENTIATION AND TRANSFORMATION OF MAMMARY EPITHELIAL-CELLS

      Journal of Cell Science
    84. SHAWVER LK; MANN E; ELLIGER SS; DUGGER TC; ARTEAGA CL
      LIGAND-LIKE EFFECTS INDUCED BY ANTI-C-ERBB-2 ANTIBODIES DO NOT CORRELATE WITH AND ARE NOT REQUIRED FOR GROWTH-INHIBITION OF HUMAN CARCINOMA-CELLS

      Cancer research
    85. RUBIN SC; FINSTAD CL; FEDERICI MG; SCHEINER L; LLOYD KO; HOSKINS WJ
      PREVALENCE AND SIGNIFICANCE OF HER-2 NEU EXPRESSION IN EARLY EPITHELIAL OVARIAN-CANCER/

      Cancer
    86. KIHANA T; TSUDA H; TESHIMA S; NOMOTO K; TSUGANE S; SONODA T; MATSUURA S; HIROHASHI S
      PROGNOSTIC-SIGNIFICANCE OF THE OVEREXPRESSION OF C-ERBB-2 PROTEIN IN ADENOCARCINOMA OF THE UTERINE CERVIX

      Cancer
    87. ANTONIOTTI S; TAVERNA D; MAGGIORA P; SAPEI ML; HYNES NE; DEBORTOLI M
      ESTROGEN AND EPIDERMAL GROWTH-FACTOR DOWN-REGULATE ERBB-2 ONCOGENE PROTEIN EXPRESSION IN BREAST-CANCER CELLS BY DIFFERENT MECHANISMS

      British Journal of Cancer
    88. BACUS SS; ZELNICK CR; CHIN DM; YARDEN Y; KAMINSKY DB; BENNINGTON J; WEN DZ; MARCUS JN; PAGE DL
      MEDULLARY CARCINOMA IS ASSOCIATED WITH EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATION TO ITS MORPHOLOGY AND ITS CLINICAL BEHAVIOR

      The American journal of pathology
    89. MATIN A; HUNG MC
      NEGATIVE REGULATION OF THE NEU PROMOTER BY THE SV40 LARGE T-ANTIGEN

      Cell growth & differentiation
    90. ISSING WJ; HEPPT WJ; KASTENBAUER ER
      ERBB-3, A 3RD MEMBER OF THE ERBB EPIDERMAL GROWTH-FACTOR RECEPTOR GENE FAMILY - ITS EXPRESSION IN HEAD AND NECK-CANCER CELL-LINES/

      European archives of oto-rhino-laryngology
    91. ISSING WJ; DREPS A; HEPPT WJ; WUSTROW TPU; RIEDERER A; ZAGURY JF
      ERBB-2 HER-2 GENE AMPLIFICATION AND OVEREXPRESSION IN PAROTID-GLAND TUMORS/

      European archives of oto-rhino-laryngology
    92. LUO JC; YU MW; CHEN CJ; SANTELLA RM; CARNEY WP; BRANDTRAUF PW
      SERUM C-ERBB-2 ONCOPEPTIDE IN HEPATOCELLULAR CARCINOGENESIS

      Medical science research
    93. BREUER B; LUO JC; DEVIVO I; PINCUS M; TATUM AH; DAUCHER J; MINICK R; OSBORNE M; MILLER D; NOWAK E; CODY H; CARNEY WP; BRANDTRAUF PW
      DETECTION OF ELEVATED C-ERBB-2 ONCOPROTEIN IN THE SERUM AND TISSUE INBREAST-CANCER

      Medical science research
    94. NAUNDORF H; FICHTNER I; SAUL GJ; HAENSCH W; BUTTNER B
      ESTABLISHMENT AND CHARACTERISTICS OF 2 NEW HUMAN MAMMARY-CARCINOMA LINES SERIALLY TRANSPLANTABLE IN NUDE-MICE

      Journal of cancer research and clinical oncology
    95. YAMANAKA Y; FRIESS H; KOBRIN MS; BUCHLER M; KUNZ J; BEGER HG; KORC M
      OVEREXPRESSION OF HER2 NEU ONCOGENE IN HUMAN PANCREATIC-CARCINOMA/

      Human pathology
    96. NAGAI MA; MARQUES LA; TORLONI H; BRENTANI MM
      GENETIC ALTERATIONS IN C-ERBB-2 PROTOONCOGENE AS PROGNOSTIC MARKERS IN HUMAN PRIMARY BREAST-TUMORS

      Oncology
    97. CULOUSCOU JM; PLOWMAN GD; CARLTON GW; GREEN JM; SHOYAB M
      CHARACTERIZATION OF A BREAST-CANCER CELL-DIFFERENTIATION FACTOR THAT SPECIFICALLY ACTIVATES THE HER4 P180(ERBB4) RECEPTOR/

      The Journal of biological chemistry
    98. BACUS SS; GUDKOV AV; ZELNICK CR; CHIN D; STERN R; STANCOVSKI I; PELES E; BENBARUCH N; FARBSTEIN H; LUPU R; WEN DZ; SELA M; YARDEN Y
      NEU DIFFERENTIATION FACTOR (HEREGULIN) INDUCES EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATIONS FOR MAMMARY-TUMORS

      Cancer research
    99. SHAW GL; SRIVASTAVA S
      MEETING HIGHLIGHTS - NATIONAL-CANCER-INSTITUTE WORKSHOP ON EARLY DETECTION OF CANCER - CHALLENGES FOR MOLECULAR-BIOLOGY

      Journal of the National Cancer Institute
    100. NIEHANS GA; SINGLETON TP; DYKOSKI D; KIANG DT
      STABILITY OF HER-2 NEU EXPRESSION OVER TIME AND AT MULTIPLE METASTATIC SITES/

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 16:48:31